VRTX — Vertex Pharmaceuticals Incorporated Share News
0.000.00%
Last trade - 00:00- $128.95bn
- $121.10bn
- $12.00bn
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify
Vertex rises after kidney disease drug shows promise in mid-stage study
Brief: Vertex Pharmaceuticals Incorporated Says Inaxaplin Reduces UACR By -42.7% At Week 13 In AMKD With Modest Proteinuria
U.S. STOCKS ON THE MOVE-Microsoft, Coastal Financial, Eli Lilly
U.S. STOCKS ON THE MOVE-Microsoft, Coastal Financial
Vertex Pharma rises after rival genetic disorder drug setback
U.S. STOCKS ON THE MOVE-SpaceX, AAON, Vertex Pharma
Vertex Pharma rises after rival genetic disorder drug setback
Sionna scraps genetic disorder drug program after trial setback; shares tank
Vertex Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Vertex Q2 revenue beats estimates on strong demand for cystic fibrosis therapies, lifts outlook
Vertex raises annual revenue forecast on cystic fibrosis drugs strength
Deals of the day-Mergers and acquisitions
Crinetics soars as Vertex agrees to $10 billion buyout deal
Deals of the day-Mergers and acquisitions
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Deals of the day-Mergers and acquisitions
U.S. RESEARCH ROUNDUP- BlackRock, Eli Lilly, Goldman Sachs